[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Bentley InnoMed GmbH\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":60},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,38],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":27,"lastUpdatePostDateStruct":28,"startDateStruct":31,"completionDateStruct":33,"leadSponsor":35,"locationsCount":4},"100615633","bentley-bridging-stent-graft-study-100615633",false,"NCT07295145","Bentley Bridging Stent Graft Study","BeFab: An International, Multi-centre Observational Study to Evaluate Safety, Performance, and Clinical Benefit of Bentley Bridging Stent Graft Systems","BeFab","Inclusion Criteria:\n\n* Adult patients having complex abdominal aortic aneurysms suitable for an endovascular repair with a fenestrated and\u002For branched aortic endovascular graft in combination with one Bentley bridging stent graft per reno-visceral artery in accordance with the IFU of BeFlared, BeGraft or BeGraft Plus. Use of different products for different target vessels is allowed. Use of stents from other manufacturers for other reno-visceral arteries is allowed.\n* Patient is capable and willing to sign the informed consent and agrees to fulfil follow-up requirements\n* Patients ≥18 years of age at the time of consent\n\nExclusion Criteria:\n\n* Patients with contraindications as listed in the IFUs\n* Previous stenting of the target vessel\n* Extension\u002Frelining of Bentley BSGs\n* Prior EVAR procedure","ALL","18 Years",{"count":20,"type":21},150,"ESTIMATED","OBSERVATIONAL","This international, observational multi-centre observational study of the devices BeFlared FEVAR Stent Graft System (BeFlared), BeGraft Stent Graft System (BeGraft), and BeGraft Plus Stent Graft System (BeGraft Plus) will monitor technical success of the implantation, data regarding clinical performance, clinical benefit, as well as potential unknown side effects for the use as bridging stent grafts in combination with fenestrated aortic endovascular grafts.",[25],"Aortic Aneurysm","NOT_YET_RECRUITING","2025-12-16",{"date":29,"type":30},"2025-12-19","ACTUAL",{"date":32,"type":21},"2026-01",{"date":34,"type":21},"2031-12",{"name":36,"class":37},"Bentley InnoMed GmbH","INDUSTRY",{"id":39,"slug":40,"hasResults":11,"nctId":41,"briefTitle":42,"officialTitle":43,"acronym":4,"eligibilityCriteria":44,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":45,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":47,"conditions":48,"keywords":4,"overallStatus":51,"whyStopped":4,"lastUpdateSubmitDate":52,"lastUpdatePostDateStruct":53,"startDateStruct":55,"completionDateStruct":57,"leadSponsor":59,"locationsCount":5},"100593739","an-observational-study-to-evaluate-safety-performance-and-clinical-benefit-of-beflow-100593739","NCT07010354","An Observational Study to Evaluate Safety, Performance, and Clinical Benefit of BeFlow","An International, Multi-centre Observational Study to Evaluate Safety, Performance, and Clinical Benefit of the BeFlow Iliac Covered Stent System","Inclusion Criteria:\n\n* Patients with an indication for permanent intraluminal placement in iliac arteries for restoring and improving the patency impaired by arteriosclerosis or other stenoses that may be treated by stenting according to the IFU of the BFI\n* Patient is capable and willing to sign an informed consent\n* Patients ≥18 years of age at the time of consent\n\nExclusion Criteria:\n\n* Patients with any contraindication according to the IFU\n* Previous stenting of the target vessel",{"count":46,"type":21},100,"This international, observational multi-centre study of the device BFI will monitor technical success of the implantation, data regarding clinical performance, clinical benefit, as well as potential unknown side effects pursuant to the Intended Purpose.",[49,50],"Iliac Artery Stenosis","Iliac Artery Occlusion","RECRUITING","2025-09-15",{"date":54,"type":30},"2025-09-19",{"date":56,"type":30},"2025-08-08",{"date":58,"type":21},"2031-07-31",{"name":36,"class":37},""]